Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
HGG Advances|July 28, 2025
De novo missense variants in CHTF18: The potential to expand the clinical spectrum of cohesinopathiesErfan Aref-Eshghi, Ingrid M Wentzensen, Tawfeg Ben-Omran, et al.Arthritis and Rheumatism|February 28, 2009
The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease statesNicholas Knowlton, Kaiyu Jiang, Mark Barton Frank, et al.Arthritis Research & Therapy|September 28, 2006
Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritisJames N Jarvis, Howard R Petty, Yuhong Tang, et al.Arthritis and Rheumatism|May 1, 2009
Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritisJames N Jarvis, Kaiyu Jiang, Mark Barton Frank, et al.Journal of Medicinal Chemistry|February 6, 2009
Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitorsHui Huang, Daniel A Hutta, James M Rinker, et al.Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.International Journal of Cancer|July 3, 2019
Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genesQianqian Zhu, Jianmin Zhang, Yanmin Chen, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitorsKenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.Pageof 11